Doerring, M.D., former FDA medical officer in the division of psychiatry and the founder and CEO of TaperClinic, he shares ...

It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks ...

Crohn's disease is a type of inflammatory bowel disease (IBD) that causes swelling and irritation of the tissues, called ...

Pharmaceutical firms may consult with health authorities individually to speed up process under streamlined drug approval ...

The agency OK’d an artificial vessel to restore blood flow in patients, even though its own scientists flagged questionable ...

The FDA recently approved an immunotherapy-based treatment option that can be administered by under the skin, injection. This ...

The U.S. Food and Drug Administration (FDA) has approved a new drug for a serious heart condition that affects thousands of ...

The European Medicines Agency accepts GSK's regulatory filing for expanded use of Nucala to treat COPD for review.

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

Bajaj Healthcare’s stock has surged, fuelled by regulatory approvals and expansion into high-growth markets. But with a ...

McGill researchers found lecanemab may be less effective in women, prompting calls for more personalized treatment and ...